SCHEMBL1573922

SCHEMBL1573922

Nc1ccccc1N[C@H]1C[C@H]2COC[C@@H](C1)N2C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
HDAC1 Q13547 13/20 0.38
HDAC2 Q92769 12/20 0.38
HDAC3 O15379 10/20 0.38
MAPK1 P28482 1/20 0.38
HDAC4 P56524 4/20 0.37
HDAC7 Q8WUI4 4/20 0.37
HDAC10 Q969S8 4/20 0.37
HDAC11 Q96DB2 4/20 0.37
HDAC8 Q9BY41 4/20 0.37
HDAC6 Q9UBN7 4/20 0.37
HDAC9 Q9UKV0 4/20 0.37
HDAC5 Q9UQL6 4/20 0.37
NCOR2 Q9Y618 3/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
MAPK13 O15264 1/20 0.35
MAPK12 P53778 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1573923 1.00 KDM4E (0.44) KDM4EGAAMAPTHDAC1HDAC2
SCHEMBL4396685 0.89 GAA (0.50) KDM4EGAAMAPTHDAC1HDAC2
SCHEMBL7226906 0.89 GAA (0.50) KDM4EGAAMAPTHDAC1HDAC2
SCHEMBL7237208 0.89 GAA (0.50) KDM4EGAAMAPTHDAC1HDAC2
SCHEMBL1573769 0.80 MAPK1 (0.48) GAAMAPTMAPK1NPC1RAB9A
SCHEMBL1573767 0.80 MAPK1 (0.48) GAAMAPTMAPK1NPC1RAB9A
SCHEMBL13221824 0.76 KDM4E (0.59) KDM4EGAAMAPTHDAC1HDAC2
SCHEMBL15854061 0.76 KDM4E (0.48) KDM4EGAAMAPTHDAC1HDAC2
SCHEMBL17030967 0.76 KDM4E (0.48) KDM4EGAAMAPTHDAC1HDAC2
SCHEMBL17030966 0.76 KDM4E (0.48) KDM4EGAAMAPTHDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140085-B1 AZABICYCLOALKANES AS CCR5 MODULATORS PHIVCO UK LTD (GB) 2011-04-13 EP disclosed
US-6586430-B1 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders PFIZER INC. 2003-07-01 US disclosed